Purchase Order 75D30124P20140
Award Date 9/11/24
Potential Completion Date 8/30/29
Potential Value $245K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order contract to Illumina, Inc. for a maintenance agreement on three Illumina MiSeq sequencing instruments. The contract has a ceiling value of $42,987.00 and a period of performance through September 15, 2024. Illumina is a manufacturer of genomic sequencing and analysis solutions that has supported numerous federal agencies, including the National Institutes of Health (NIH), U.S. Department of...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $223,532.40, is for the maintenance and services of Illumina sequencing instruments. The contract has an ultimate completion date of April 4, 2025 and does not utilize any set-aside designations. Illumina, headquartered in San Diego, California, is a...
- This is a $18,768.00 firm fixed-price purchase order awarded to Illumina, Inc., a for-profit manufacturer of genetic sequencing and genomic analysis technologies, by the Centers for Disease Control and Prevention (CDC) on July 14, 2019. The contract, which has an ultimate completion date of September 29, 2024, is for the provision of equipment maintenance services. The contract is not set aside for any specific business category. Illumina holds two significant federal Indefinite Delivery...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order contract worth $13,907.30 to Illumina, Inc. for the maintenance of laboratory equipment. The contract has a period of performance through July 20, 2024 and does not have a socioeconomic set-aside designation. Illumina is a manufacturer and provider of genetic and genomic analysis instruments and reagents, and has previously provided sequencing systems and services to support research and...
- The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $247,008.03 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing and analysis products. The contract is for the provision of laboratory supplies, with a completion date of May 31, 2024. Illumina has previously received federal awards from agencies such as the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and...
- This federal contract award to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies, was issued by the Centers for Disease Control and Prevention (CDC) for a MiSeq Silver Plan asset. The $176,416.32 firm fixed-price purchase order has an ultimate completion date of July 20, 2029. Illumina has been awarded multiple federal contracts and Indefinite Delivery Vehicles (IDVs) from agencies such as the U.S. Department of Agriculture (USDA) and...
- This federal contract award to Illumina, Inc. is for the procurement of a MiSeq System, a genetic sequencing platform and associated consumables and services. The $93,529 firm fixed price contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The contract does not have a set-aside designation. Illumina is a leading manufacturer of advanced genetic sequencing instruments, reagents, and bioinformatics software. The company has been awarded multiple federal...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $144,302.41 contract provides supplies - chemicals to support the agency's research and diagnostics needs. This award does not have a set-aside designation. Illumina has previously been awarded prime federal contracts by agencies such as NIH, USDA,...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for the provision of an ILLUMINA NS 1000 INSTRUMENT. The potential value of this award is $205,800.00. Illumina has previously received prime federal contract awards from various agencies like the NIH, CDC, USDA, and VA to provide a range of genomic sequencing systems, consumables, and...
- Illumina, Inc. was awarded a $11,922.64 purchase order by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh for unspecified goods or services to be delivered to San Diego, California. The award was made on a firm fixed price basis with no set-aside designation. As a manufacturer and provider of sequencing and array-based solutions, Illumina likely will supply various sequencing systems, reagents, consumables, or related bioinformatics products to...